Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Novel Multiplex Immunoassay for the Early Detection of Bladder Cancer

NCT05347342 is registered in ClinicalTrials.gov with Cedars-Sinai Medical Center as lead sponsor.

NCT NCT05347342
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05347342 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Novel Multiplex Immunoassay for the Early Detection of Bladder Cancer
Lead sponsor
Cedars-Sinai Medical Center
Phase
Observational
Overall status
Active, not recruiting
Start date
April 29, 2022
Completion date
January 31, 2029
Enrollment
173 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

bladder cancer